Skip to main content
. 2022 Dec 7;2022(12):CD015477. doi: 10.1002/14651858.CD015477

19.

19

Analysis 2.2.2: SII‐ChAdOx1 versus ChAdOx1. Outcome: serious adverse events (SAEs).